Fischer Medical Ventures Share Price Today | Stock Price & Fischer Medical Ventures Share Screener
As of October 5, 2026, the live Fischer Medical Ventures share price (NSE: FISCHER) is ₹32.80 on NSE and ₹32.87 on BSE, down 1.97% from the previous close, with shares trading between ₹32.66 and ₹33.83 in today's trading session, and a 52-week range of ₹31.21–₹117.71. Check FISCHER annual price range for the annual price range and momentum. Use the Fischer Medical Ventures stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Fischer Medical Ventures opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹83 and net income of ₹4, with EBITDA of ₹13, an operating margin of 14.0% and a profit margin of 4.8%.
Fischer Medical Ventures Share Price Chart
Track the current stock price of Fischer Medical Ventures with an interactive chart. Analyse FISCHER share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Fischer Medical Ventures stock quote in one place.
The quote of ₹32.80 sits between the 52-week low of ₹31.21 and the 52-week high of ₹117.71, and the latest session moved -1.97% from the previous close.
Fischer Medical Ventures Company Profile - Fundamental Screener
Screen Fischer Medical Ventures company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for FISCHER shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Chemicals sector and the Commodity Chemicals industry, and it trades under ISIN INE771F01041.
Company Details
Classification
Identifiers and Leadership
Fischer Medical Ventures Balance Sheet Screener
Screen FISCHER balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹671, up from ₹457 in 2025.
Latest statistics put total assets at ₹671 and shareholder funds at ₹385, with a leverage ratio of 0.27.
| Item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
Assets |
||||
| Total Assets | 671 | 457 | 86 | 0 |
| Current Assets | 418 | 365 | 70 | 0 |
| Fixed Assets | 32 | 24 | 15 | 0 |
Liabilities |
||||
| Total Liabilities | 0 | 0 | 0 | 0 |
| Current Liabilities | 28 | 18 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||
| Total Equity | 385 | 338 | 81 | 0 |
| Share Capital | 66 | 64 | 54 | 0 |
| Reserves & Surplus | 320 | 244 | 27 | 0 |
Fischer Medical Ventures Income Statement Screener - Profit & Revenue Analysis
Screen Fischer Medical Ventures income statement and profit fundamentals. Analyze FISCHER quarterly results. Fischer Medical Ventures reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹83 and net profit was ₹4, equal to earnings per unit of ₹0.06, at an operating margin of 14%.
In that period expenses were ₹71, interest cost ₹4 and tax ₹4. The next period listed, 2026-Mar, shows revenue of ₹98 and net profit of ₹-12.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||
| Revenue | 83 | 98 | 102 | 89 | 31 | 49 | 12 | 40 | 11 | 21 | 0 | 0 | 0 |
| Expenses | 71 | 101 | 80 | 70 | 20 | 47 | 11 | 39 | 10 | 18 | 1 | 0 | 0 |
Operating Costs and Margins | |||||||||||||
| EBITDA | 13 | -3 | 23 | 19 | 12 | 3 | 1 | 1 | 1 | 3 | -1 | 0 | 0 |
| Operating Profit % | 14.00% | -4.00% | 21.00% | 19.00% | 17.00% | 5.00% | 3.00% | 1.00% | -3.00% | 12.00% | -347.00% | 0.00% | 0.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 4 | 4 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||
| Profit Before Tax | 8 | -8 | 21 | 17 | 10 | 2 | 0 | 0 | 0 | 3 | -1 | 0 | 0 |
| Tax | 4 | 5 | 2 | 3 | 5 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 4 | -12 | 19 | 14 | 5 | 1 | 0 | 0 | 0 | 3 | -1 | 0 | 0 |
| EPS | 0.06 | -0.19 | 0.30 | 0.22 | 0.08 | -0.05 | -0.05 | 0.05 | 0.65 | 0.48 | 0.00 | 0.00 | 0.00 |
Fischer Medical Ventures Cash Flow Screener - Liquidity Fundamentals
Screen FISCHER cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹101, and net cash flow was an outflow of ₹92.
Over the same period, investing activities used ₹5 and financing activities provided ₹14.
| Item | 2026-March | 2025-March | 2024-March |
|---|---|---|---|
Cash from Operations and Investing | |||
| Operating Activities | -101 | -86 | -7 |
| Investing Activities | -5 | -125 | -29 |
Financing and Net Cash | |||
| Financing Activities | 14 | 315 | 37 |
| Net Cash Flow | -92 | 103 | 1 |
Fischer Medical Ventures Shareholding Pattern Screener
See Fischer Medical Ventures shareholding pattern with promoter, FII, and DII holdings. Check Fischer Medical Ventures promoter holding and ownership changes for FISCHER on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Aug, promoters held 63.08%, foreign institutions 5.57%, domestic institutions 1.26% and the public 23.82%, spread across 23,951 shareholders.
The shareholder count was 23,951 in 2026-Aug, compared with 23,950 in 2026-Jun.
| Item | 2026-Aug | 2026-Jun | 2026-Mar | 2025-Feb | 2025-Mar | 2025-Apr | 2025-Jun | 2025-Jul |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 63.08% | 62.15% | 62.15% | 62.81% | 62.81% | 61.80% | 61.80% | 61.80% |
Institutional Investors | ||||||||
| FII Holding | 5.57% | 5.48% | 4.97% | 5.06% | 5.23% | 5.38% | 5.55% | 0.00% |
| DII Holding | 1.26% | 1.35% | 1.38% | 1.41% | 1.44% | 1.42% | 1.42% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.82% | 24.33% | 24.91% | 25.30% | 26.52% | 27.48% | 26.48% | 26.47% |
| Other Holding | 6.27% | 6.69% | 6.59% | 5.41% | 3.99% | 3.93% | 4.75% | 11.74% |
| Shareholder Count | 23,951 | 23,950 | 23,269 | 9,865 | 10,180 | 10,182 | 10,058 | 10,050 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Fischer Medical Ventures. Fischer Medical Ventures dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.05 per unit for 2026-March, a yield of 0.15%, compared with ₹0.05 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.05, ₹0.05 and ₹0.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.05 | 0.15% |
| 2025-March | ₹0.05 | 0.12% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Fischer Medical Ventures Stock Index Membership - Nifty & Sensex
See which indices include Fischer Medical Ventures stock. Check FISCHER index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Fischer Medical Ventures Market Events Screener - Corporate Actions
Get Fischer Medical Ventures corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Fischer Medical Ventures stock events that may affect FISCHER share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.
It is followed by Dividend dated September 22, 2026 and Quarterly Result Announcement dated August 14, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | -10.03% |
| 2026-09-22 | 2026-09-22 | Dividend | ₹ 0.05 /share | -12.35% |
| 2026-08-14 | 2026-08-14 | Quarterly Result Announcement | NA | 3.15% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 2.80% |
| 2026-01-30 | 2026-01-30 | Quarterly Result Announcement | NA | 1.07% |
| 2025-10-28 | 2025-10-28 | Quarterly Result Announcement | NA | 11.81% |
| 2025-09-29 | 2025-09-29 | Annual General Meeting | NA | 18.86% |
| 2025-09-22 | 2025-09-22 | Dividend | ₹ 0.00 /share | 33.62% |
| 2025-09-12 | 2025-09-12 | Split | 1:10 | 19.86% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -1.86% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 2.45% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 1.26% |
| 2025-01-31 | 2025-01-31 | Extraordinary General Meeting | NA | 0.40% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 2.38% |
| 2024-09-17 | 2024-09-17 | Annual General Meeting | NA | -2.43% |
Fischer Medical Ventures Competitors Screener - Peer Stocks Comparison
Screen FISCHER competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Tata Chemicals | 15,484 | -7.86 | 14,900 | -1.40% | -1,715 | 39.22 |
| Gujarat Narmada Valley Fert & Chem | 8,657 | 8.35 | 8,272 | -1.45% | 798 | 50.00 |
| TANFAC Industries | 7,051 | 104.22 | 713 | 27.42% | 70 | 45.84 |
| Gujarat Alkalies & Chemicals | 4,433 | 66.92 | 4,475 | 7.44% | -2 | 33.44 |
| Grauer & Weil | 3,709 | 23.19 | 1,240 | 5.07% | 164 | 56.64 |
| GHCL | 3,701 | 7.85 | 3,138 | -4.08% | 473 | 23.75 |
| Chemplast Sanmar | 3,029 | -7.74 | 4,252 | -3.21% | -280 | 55.53 |
| JG Chemicals | 2,392 | 30.52 | 973 | 13.40% | 70 | 50.90 |
| Fischer Medical Ventures | 2,190 | 95.71 | 321 | 186.01% | 31 | 40.39 |
| Thirumalai Chemicals | 1,763 | -11.65 | 1,754 | -15.26% | -168 | 34.40 |
Fischer Medical Ventures Company Announcements - News & Reports Screener
Screen FISCHER latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 3, 2026.
The next most recent announcements are dated October 1, 2026 and September 30, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-03 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-10-01 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-30 | General Update | - |
| 2026-09-28 | Reg. 34 (1) Annual Report. | - |
| 2026-09-27 | Closure of Trading Window | - |
| 2026-09-26 | Board Meeting Outcome for Boards Approval For Proposed Investments In Material Wholly Owned Subsidiaries | - |
| 2026-09-17 | Presentation Of Investor/Analyst Meeting | - |
| 2026-09-16 | Chairmans Message | - |
| 2026-09-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-07 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-09-07 | Reg. 34 (1) Annual Report. | - |
| 2026-09-07 | Intimation Of 33Rd AGM Of Fischer Medical Ventures Limited | - |
| 2026-09-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-03 | Record Date For E-Voting At AGM And Dividend | - |
| 2026-09-03 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-08-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-24 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-18 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹32.80, within a 52-week range of ₹31.21 to ₹117.71. The P/E ratio is 95.71 and the P/B ratio is 4.79, with earnings per unit of ₹0.48. Market capitalisation stands at ₹2,190.01 Cr and the dividend yield is 0.01%. The company operates in the Chemicals sector, in the Commodity Chemicals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 4 balance sheet periods, 13 income statement periods, 3 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.